Intratumoral injection of ultrasonically prepared emulsions of the synthetic glycolipid methyl 6-0-(2-tetradecyl-3-hydroxyoctadecanoyl)-a-D-glucopyranoside (designated C39) induced complete regression of transplants of a syngeneic murine fibrosarcoma in most of the treated animals as did 6,6'-di-O-(2-tetradecyl-3-hydroxyoctadecanoyl)-a,a-trehalose (designated C76) in a previous study. The C76 compound, about twice the molecular weight of C39, was more effective therapeutically than the smaller molecule. Ultrasonically prepared emulsions of C39 and C76 were not toxic when given intravenously. Intravenously administered emulsions of C39 prepared by mechanical grinding were more toxic, but less granulomagenic, than those containing C76. Squalane and squalene, but not peanut oil, were effective substitutes for mineral oil as carriers of C39 in the treatment of the tumor.
Injection of trehalose-6,6'-dimycolate (TDM), a mycobacterial glycolipid known also as cord factor, into animals produces some of the biological effects of mycobacterial infection (5) . One of these effects is regression of established transplants of a syngeneic murine fibrosarcoma (13) . Injection of ultrasonically prepared emulsified 6,6'-di-O-(2-tetradecyl-3-hydroxyoctadecanoyl)-a,a-trehalose, designated C76, a synthetic analog of TDM, into transplants of a murine fibrosarcoma induced complete regression of the tumor (17) . Intravenously (i.v.) administered emulsions of C76 (prepared by grinding) were less toxic and less granulomagenic than those made with TDM (17) . The work reported here is part of a study to investigate the relationship between the chemical structure of synthetic compounds related to TDM and their tumor-regressive potency. Methyl 6-0-(2'-tetradecyl-3'-hydroxyoctadecanoyl)-a-D-glucopyranoside, designated C39, can be considered to be "half' of the C76 molecule (Fig. 1) . In this study we investigated the antitumor activity, toxicity, and granulom- Compounds tested. TDM from Mycobacterium bovis AN5 (Institut Pasteur) was isolated by A. Escaut at the Pilot plant of the Institut de Chimie des Substances Naturelles, Centre National de la Recherche Scientifique, at Gif-sur-Yvette, France. The synthetic C76 was prepared as described previously (7, 8) . C39 was prepared by reacting 6-0-tosyl methyl a-D-glucopyranoside (1) with the potassium salt of synthetic erythro or threo (a or fi) 2-tetradecyl-3-hydroxyoctadecanoic acid (8) We have reported that emulsions of C76 were less toxic than those of TDM (17) . We Table 4 showed that under the (mg) d C39 or C76 emulsions were ground for 2 min and then inoculated i.v. or were further treated ultrasonically for 2 min and then inoculated. In the ground preparations about 50% of the oil droplets were larger than 1 am; after an ultrasonic treatment for 2 min-only 1% of the oil droplets were larger than 1 Am. present experimental conditions administration of emulsified TDM brought about 100% lethality. C76 killed 1 out of 10 mice, and the surviving animals lost a significant amount of weight (up to 25%); they regained it within 3 weeks. In contrast, no deaths occurred after inoculation of C39, and the loss of weight was comparable to that of the emulsion control group (up to 2%). The toxicity of C39 was further evaluated with doses up to 3 mg per mouse and compared to that of C76 (Table 4, experiment 3) . By the i.v. route it was found that ground emulsions of C39 were more lethal than those of C76. However, mice which survived after i.v. injection of C39 regained their weight within 1 week, whereas mice which survived after C76 administration regained their weight only after 2 to 3 weeks. Under the test conditions, animals treated with C39 died within a few hours of treatment, whereas those treated with TDM died after several days (up to 14) elapsed. A fourth experiment (Table 4) showed that ultrasonic treatment of the C39 emulsion prepared by grinding yielded a product with oil droplets that were smaller than those in the ground preparation; the emulsion with the smaller oil droplets was less toxic than that with the larger oil droplets. DISCUSSION The results of the present study indicate that intralesional administration of ultrasonically prepared emulsified C39, a synthetic compound related to cord factor, caused regression of established, syngeneic tumors in mice. We have reported that the toxicity and granulomagenic activity ofTDM emulsions administered i.v. into mice depended on the size distribution of the mineral oil droplets. Emulsions containing the greatest number of the largest oil droplets were the most granulomagenic and the most toxic (14, 15) . Ultrasonically prepared emulsions of TDM given i.v. were less granulomagenic and not detectably toxic (14, 15) , but were highly effective in the regression of murine tumors when administered intralesionally (17) . Ground emulsions of C39 were not toxic and minimally granulomagenic at a dose (0.1 mg/mouse) that had effective antitumor activity, although the size distribution of the oil droplets in those emulsions was comparable to that of C76 or TDM emulsions. At a dose of 1 mg/mouse, ground emulsions of C39 given i.v. were highly lethal, but those of C76 activity (17; E. Yarkoni, L. P. Ruco, H. J. Rapp, and M. S. Meltzer, Eur. J. Cancer, in press). The results of the present study support these findings.
We have suggested that the number of carbon atoms in the fatty acid portion of trehalose diesters may be an important determinant for antitumor activity. Trehalose diesters of palmitic acid (16 carbon atoms in each fatty acid portion) and behenic acid (22 carbon atoms in each fatty acid portion) were minimally active against 5-day-old 1023 tumors, whereas a trehalose diester with 32 carbon atoms in each fatty acid portion (C76) and one with 80 to 90 carbon atoms (TDM; Fig. 1 ) were active (17) . Other investigators showed that naturally occurring trehalose monomycolates and their synthetic analogs were as active as TDM in regressing tumors in guinea pigs, but only when they were combined with endotoxin (10, 12) . In our murine tumor system, endotoxin was not required to cause tumor regression by TDM, C76, or C39. C39 may be considered to be "half' of the C76 molecule. The present study also indicated that there may be a relationship between the chemical structure of the agent and the type of oil required for it to be optimally active. Emulsions of SQA or SQE, but not PNO, were effective substitutes for mineral oil as carriers of C39 in the treatment of the tumor. TDM was therapeutically active when it was incorporated in any of these four oils (16). We do not know what determines whether a particular oil will serve as an effective carrier of synthetic compounds related to mycobacterial fractions that have antitumor activity.
SQA and SQE have some advantages over mineral oil in the preparation of emulsified vaccines for cancer immunotherapy. SQE is an intermediate product in the biosynthesis of cholesterol; its structure is known and it can be synthesized in vitro (4) . SQA is obtained by complete hydrogenation of SQE; but it may be less digestible than SQE. Because, unlike mineral oil, SQE and SQA are chemically defined pure compounds, their use might facilitate studies of the mechanism of cancer immunotherapy.
The availability of synthetic compounds for cancer immunotherapy offers an opportunity to explore the relationships between the chemical structure of the agent and its tumor regressive potency. The results of such studies may permit the design of molecules with antitumor activity and without unwanted side effects.
